Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eureka! Venture is an independent Italian venture capital asset management company focused on deep tech investments, with activity spanning science-based and digital technology opportunities. The firm manages venture funds including Eureka! Fund I – Technology Transfer, which backs proof-of-concept, spin-out, seed, and early-stage companies emerging from Italian universities and research centers, and has invested in health and well-being companies alongside materials, energy, mobility, environment, and AI sectors. In healthcare, its role is as an investor rather than a drug developer, with portfolio exposure to medtech and health-tech companies such as WISE, Endostart, and INTA Systems. The company is authorized by the Bank of Italy and appears to operate as a private fund manager headquartered in Milan with an additional office in Rome. For a biotech analyst, this is best understood as a healthcare-relevant venture investor and technology transfer platform, not an operating biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EUREKA! Venture SGR.